NCT00278148View on ClinicalTrials.gov

Erlotinib, Paclitaxel, and Carboplatin Combined With Radiation Therapy for Stage III Non-Small Cell Lung Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions
Lung Cancer
Interventions
DRUG

carboplatin

AUC2 weekly x 3 weeks

DRUG

Erlotinib

Daily

DRUG

paclitaxel

50mg/m2/weekly x 3 weeks

PROCEDURE

conventional surgery

conventional surgery

RADIATION

radiation therapy

150 cGy bid

Trial Locations (1)

44195

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Nathan Pennell, MD, PhD

OTHER

NCT00278148 - Erlotinib, Paclitaxel, and Carboplatin Combined With Radiation Therapy for Stage III Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter